“Narcos: Mexico” star Manuel Masalva is reportedly “fighting for his life” in an “induced coma” after contracting an aggressive bacterial infection while abroad. The 43-year-old actor ...

Narcos isn’t just about drugs. It’s about power, paranoia, and the slow unraveling of a system built on fear. The series on Netflix kicks off with the rise and fall of Pablo Escobar, played by ...

The U.S. Treasury imposes sanctions on entities linked to drug trafficking and oil smuggling connected to the CJNG gang.

Narcos: Mexico actor Manuel Masalva remains in critical but stable condition after being placed in a medically induced coma following the contraction of a “very aggressive bacteria” while ...

“Narcos: Mexico” actor Manuel Masalva is in a medically induced coma after contracting a “very aggressive” bacterial infection while on vacation. “My brother is fighting for his life far ...

Actor Manuel Masalva, known for his work in Netflix’s “Narcos: Mexico,” is currently hospitalized in a medically-induced coma in Dubai after contracting a highly infectious bacteria while ...

Jaime Jaramillo Espinosa, the CEO of Mexican management agency JIM Management and Masalva’s manager, first relayed the news to the Los Angeles Times, which reported that Masalva is currently ...

Manuel Masalva, who is known for his role in "Narcos: Mexico," is in medical coma after contracting an aggressive bacterial infection following his recent trip to the Philippines. According to the Los ...

Narcos: Mexico star Manuel Masalva has been placed in a coma after contracting a bacterial infection. “My brother is fighting for his life far away from home,” Masalva’s friend Mario Morán ...

An actor known for his role in “Narcos: Mexico” is in a medically induced coma after contracting an aggressive bacterial infection while traveling. Manuel Masalva is being treated in Dubai ...

Narcos: Mexico star Manuel Masalva is in a medically induced coma after contracting a “very aggressive” bacterial infection while traveling in the Philippines. The Los Angeles Times reports ...